REMATCH and Beyond: The Cost of Treating Heart Failure Using an Implantable Left Ventricular Assist Device

被引：5
作者：
Dembitsky, Walter P.
机构：
来源：
SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2006年 / 10卷 / 03期
关键词：
cost for congestive heart failure; cost for left ventricular assist devices; REMATCH;
D O I：
10.1177/1089253206291148
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Congestive heart failure is an increasingly widespread debilitating fatal condition that generates a high cost to patients, society, and health care systems. Nearly 6.5 million people in Europe and 5 million people in the United States have congestive heart failure. Unlike most cardiovascular diseases in industrialized countries, congestive heart failure is becoming more common. Therapies include medical approaches, implantable assist devices, and cardiac transplantation. Mechanical assistance devices rather than medical therapy offer improvement in quality of life and survival.
引用
收藏
页码：253 / 255
页数：3
相关论文
共 11 条
  • [1] American Heart Association, 2005, HEART DIS STROK STAT
  • [2] Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study
    Bleumink, GS
    Knetsch, AM
    Sturkenboom, MCJM
    Straus, SMJM
    Hofman, A
    Deckers, JW
    Witteman, JCM
    Stricker, BHC
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (18) : 1614 - 1619
  • [3] Economic burden of heart failure: A summary of recent literature
    Lee, WC
    Chavez, YE
    Baker, T
    Luce, BR
    [J]. HEART & LUNG, 2004, 33 (06): : 362 - 371
  • [4] Preferences for quality of life or survival expressed by patients with heart failure
    Lewis, EF
    Johnson, PA
    Johnson, W
    Collins, C
    Griffin, L
    Stevenson, LW
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (09) : 1016 - 1024
  • [5] Long James W, 2005, Congest Heart Fail, V11, P133, DOI 10.1111/j.1527-5299.2005.04540.x
  • [6] Epidemiology, aetiology, and prognosis of heart failure
    McMurray, JJ
    Stewart, S
    [J]. HEART, 2000, 83 (05) : 596 - 602
  • [7] McMurray JJV, 2002, EUR HEART J SUPPL, V4, pD50, DOI 10.1016/S1520-765X(02)90160-4
  • [8] Left ventricular assist devices as permanent heart failure therapy - The price of progress
    Oz, MC
    Gelijns, AC
    Miller, L
    Wang, CL
    Nickens, P
    Arons, R
    Aaronson, K
    Richenbacher, W
    van Meter, C
    Nelson, K
    Weinberg, A
    Watson, J
    Rose, EA
    Moskowitz, AJ
    [J]. ANNALS OF SURGERY, 2003, 238 (04) : 577 - 583
  • [9] Left ventricular assist devices as destination therapy: A new look at survival
    Park, SJ
    Tector, A
    Piccioni, W
    Raines, E
    Gelijns, A
    Moskowitz, A
    Rose, E
    Holman, W
    Furukawa, S
    Frazier, OH
    Dembitsky, W
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (01) : 9 - 17
  • [10] Trends in heart failure incidence and survival in a community-based population
    Roger, VL
    Weston, SA
    Redfield, MA
    Hellermann-Homan, JP
    Killian, J
    Yawn, BP
    Jacobsen, SJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03): : 344 - 350
12